FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lívia Fülöp

Research Profile

Chemicals & Drugs

Procedures

Transmission Electron Microscopy

Living Beings

Concepts & Ideas

Disorders

Alzheimer's Disease

Phenomena

Genes & Molecular Sequences

Amino Acid Sequences

Co-author Network

Publications

TOP 3
Tamás Huber; Lívia Fülöp; László Grama; Csaba Hetényi; Botond Penke; Gusztáv Schay; Miklós S Z Kellermayer
Conformational dynamics of titin PEVK explored with FRET spectroscopy.
Andrea Lakatos; Nóra V Nagy; Edit Wéber; Zita Csendes; Lívia Fülöp; Bela Gyurcsik; Tamás Kiss
Histidine-rich branched peptides as Cu(II) and Zn(II) chelators with potential therapeutic application in Alzheimer's disease.
Lívia Fülöp; Anasztázia Hetényi; Gábor Juhász; Zoltán Király; István M Mándity; Mária Benkő; Zsolt Bozsó; Dóra Simon; Viktor Szegedi; Edit Wéber; Tamás A Martinek
A foldamer-dendrimer conjugate neutralizes synaptotoxic β-amyloid oligomers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lívia Fülöp (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Tamás Huber; Lívia Fülöp; László Grama; Csaba Hetényi; Botond Penke; Gusztáv Schay; Miklós S Z Kellermayer
Conformational dynamics of titin PEVK explored with FRET spectroscopy.
Biophysical journal 2012;103(7):1480-9.
2012: Andrea Lakatos; Nóra V Nagy; Edit Wéber; Zita Csendes; Lívia Fülöp; Bela Gyurcsik; Tamás Kiss
Histidine-rich branched peptides as Cu(II) and Zn(II) chelators with potential therapeutic application in Alzheimer's disease.
Dalton transactions (Cambridge, England : 2003) 2012;41(6):1713-26.
2012: Lívia Fülöp; Anasztázia Hetényi; Gábor Juhász; Zoltán Király; István M Mándity; Mária Benkő; Zsolt Bozsó; Dóra Simon; Viktor Szegedi; Edit Wéber; Tamás A Martinek
A foldamer-dendrimer conjugate neutralizes synaptotoxic β-amyloid oligomers.
PloS one 2012;7(7):e39485.
2010: A Majzik; Lívia Fülöp; E Csapó; Ferenc Bogár; Tamás A Martinek; Botond Penke; G Bíró; Imre Dékány
Functionalization of gold nanoparticles with amino acid, beta-amyloid peptides and fragment.
Colloids and surfaces. B, Biointerfaces 2010;81(1):235-41.
2010: Eszter Sipos; Anita Kurunczi; András Fehér; Zsuzsa Penke-Verdier; Lívia Fülöp; Agnes Kasza; János Horváth; Sándor Horvát; Szilvia Veszelka; Gábor Balogh; Levente Kürti; István Eros; Piroska Szabó-Révész; Arpád Párducz; Botond Penke; Mária A Deli
Intranasal delivery of human beta-amyloid peptide in rats: effective brain targeting.
Cellular and molecular neurobiology 2010;30(3):405-13.
2010: Andrea Lakatos; Eva Zsigó; Dominik Hollender; Nóra V Nagy; Lívia Fülöp; Dora Simon; Zsolt Bozsó; Tamás Kiss
Two pyridine derivatives as potential Cu(II) and Zn(II) chelators in therapy for Alzheimer's disease.
Dalton transactions (Cambridge, England : 2003) 2010;39(5):1302-15.
2010: Zsolt Bozso; Botond Penke; Dora Simon; Ilona Laczkó; Gábor Juhász; Viktor Szegedi; Agnes Kasza; Katalin Soós; Anasztázia Hetényi; Edit Wéber; Hajnalka Tóháti; Mária Csete; Márta Zarándi; Lívia Fülöp
Controlled in situ preparation of A beta(1-42) oligomers from the isopeptide "iso-A beta(1-42)", physicochemical and biological characterization.
Peptides 2010;31(2):248-56.
2010: Gábor J Uhász; Balázs Barkóczi; Gabriella Vass; Zsolt Datki; Akos Hunya; Lívia Fülöp; Dénes Budai; Botond Penke; Viktor Szegedi
Fibrillar Abeta (1-42) enhances NMDA receptor sensitivity via the integrin signaling pathway.
Journal of Alzheimer's disease : JAD 2010;19(3):1055-67.
2009: Gábor Juhász; Arpád Márki; Gabriella Vass; Lívia Fülöp; Dénes Budai; Botond Penke; György Falkay; Viktor Szegedi
An intraperitoneally administered pentapeptide protects against Abeta (1-42) induced neuronal excitation in vivo.
Journal of Alzheimer's disease : JAD 2009;16(1):189-96.
2008: Yann Verdier; István Földi; Nicolas Sergeant; Lívia Fülöp; Zsuzsa Penke-Verdier; Tamás Janáky; Mária Szücs; Botond Penke
Characterization of the interaction between Abeta 1-42 and glyceraldehyde phosphodehydrogenase.
Journal of peptide science : an official publication of the European Peptide Society 2008;14(6):755-62.
2008: Anasztázia Hetényi; Lívia Fülöp; Tamás A Martinek; Edit Wéber; Katalin Soós; Botond Penke
Ligand-induced flocculation of neurotoxic fibrillar Abeta(1-42) by noncovalent crosslinking.
Chembiochem : a European journal of chemical biology 2008;9(5):748-57.
2007: Márta Zarándi; Katalin Soós; Lívia Fülöp; Zsolt Bozsó; Zsolt Datki; Gábor K Tóth; Botond Penke
Synthesis of Abeta[1-42] and its derivatives with improved efficiency.
Journal of peptide science : an official publication of the European Peptide Society 2007;13(2):94-9.
2006: Tamás A Martinek; István M Mándity; Lívia Fülöp; Gábor K Tóth; Elemér Vass; Miklós Hollósi; Eniko Forró; Ferenc FüLöp
Effects of the alternating backbone configuration on the secondary structure and self-assembly of beta-peptides.
Journal of the American Chemical Society 2006;128(41):13539-44.
2006: Viktor Szegedi; Gábor Juhász; Eva Rózsa; Gabriella Juhász-Vedres; Zsolt Datki; Lívia Fülöp; Zsolt Bozsó; Andrea Lakatos; Ilona Laczkó; Tamás Farkas; Zsolt Kis; Géza Tóth; Katalin Soós; Márta Zarándi; Dénes Budai; József Toldi; Botond Penke
Endomorphin-2, an endogenous tetrapeptide, protects against Abeta1-42 in vitro and in vivo.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(8):1191-3.
2006: Tamás A Martinek; Anasztázia Hetényi; Lívia Fülöp; István M Mándity; Gábor K Tóth; Imre Dékány; Ferenc FüLöp
Secondary structure dependent self-assembly of beta-peptides into nanosized fibrils and membranes.
Angewandte Chemie (International ed. in English) 2006;45(15):2396-400.
2005: Yann Verdier; Emoke Huszár; Botond Penke; Zsuzsa Penke-Verdier; Gary Woffendin; Michaela Scigelova; Lívia Fülöp; Mária Szucs; Katalin Medzihradszky; Tamás Janáky
Identification of synaptic plasma membrane proteins co-precipitated with fibrillar beta-amyloid peptide.
Journal of neurochemistry 2005;94(3):617-28.
2005: Viktor Szegedi; Lívia Fülöp; Tamás Farkas; Eva Rózsa; Hermina Robotka; Zsolt Kis; Zsuzsa Penke-Verdier; Szatmár Horváth; Zsolt Molnár; Zsolt Datki; Katalin Soós; József Toldi; Dénes Budai; Márta Zarándi; Botond Penke
Pentapeptides derived from Abeta 1-42 protect neurons from the modulatory effect of Abeta fibrils--an in vitro and in vivo electrophysiological study.
Neurobiology of disease 2005;18(3):499-508.
2004: Zsolt Datki; Rita Papp; Dénes Zádori; Katalin Soós; Lívia Fülöp; Anna Juhász; Gábor Laskay; Csaba Hetényi; Erzsébet Mihalik; Márta Zarándi; Botond Penke
In vitro model of neurotoxicity of Abeta 1-42 and neuroprotection by a pentapeptide: irreversible events during the first hour.
Neurobiology of disease 2004;17(3):507-15.
2004: Lívia Fülöp; Márta Zarándi; Zsolt Datki; Katalin Soós; Botond Penke
Beta-amyloid-derived pentapeptide RIIGLa inhibits Abeta(1-42) aggregation and toxicity.
Biochemical and biophysical research communications 2004;324(1):64-9.
2004: Zsolt Molnár; P Kovács; Ilona Laczkó; Katalin Soós; Lívia Fülöp; Botond Penke; Imre Lengyel
Enhanced G-protein activation by a mixture of Abeta(25-35), Abeta(1-40/42) and zinc.
Journal of neurochemistry 2004;89(5):1215-23.
2001: Lívia Fülöp; Botond Penke; Márta Zarándi
Synthesis and fluorescent labeling of beta-amyloid peptides.
Journal of peptide science : an official publication of the European Peptide Society 2001;7(8):397-401.